Drugs / FMP2.1/AS02A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00385047 | Sep 2006 → Apr 2007 | malaria | U.S. Army Medical Research and Development Command | Completed | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FMP2.1/AS02A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00385047 ↗ |
| Modality | Vaccine | “experimental malaria vaccine comprised of the recombinant Plasmodium falciparum protein apical membrane antigen-1 (AMA-1)” PMID 19390585 ↗ Apr 2009 |
| Route | Intramuscular | “All vaccinations were administered intramuscularly” PMID 19390585 ↗ Apr 2009 |